The Food and Drug Administration (FDA) said Tuesday in a statement it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides, Swisschems, Summit Research and Prime Peptides, four online companies it said were selling unapproved GLP-1 drugs, including semaglutide and tirzepatide. Semaglutide is known for its use…

The Hill

Washington

District of Columbia

United States

FDA warns companies over unapproved weight loss drug sales

Ad Fontes Media

All Sides

Media Bias/Fact Check

Nexstar Media Group

The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved versions of GLP-1 drugs including semaglutide and tirzepatide, the active ingredients in popular diabetes and weight-loss drugs.
The letters were issued to Xcel Peptides, Swisschems, Summit Research, and Prime Peptides last week after the U.S. health regulator conducted a review of their respective websites in October.
The w…

The Epoch Times

Epoch Media Group

New York

FDA Warns Online Vendors Selling Unapproved Weight-Loss Drugs

(Reuters) –     The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved versions of GLP-1 drugs including semaglutide and tirzepatide, the active ingredients in popular diabetes and weight-loss drugs. The letters were issued to Xcel Peptides, Swisschems, Summit Research and Prime Peptides last week after the U.S. health regulator conducted a review of their respective websites in…

WTVB

Midwest Communications

US FDA warns online vendors selling unapproved weight-loss drugs

Improper advertising on media constituted a large part of traffic directed to the companies’ websites.

pharmaceutical-technology.com

FDA targets more online vendors selling unapproved GLP-1RA products - Pharmaceutical Technology

The UK’s drug safety regulator is urging healthcare professionals to be vigilant about the misuse of obesity medications, amid growing concerns over patient misuse CREDIT: keep reading
The post Educating Patients on Responsible Use of Weight Loss Drugs first appeared on Practice Business.

practicebusiness.co.uk

Educating Patients on Responsible Use of Weight Loss Drugs

FDA warns companies over unapproved weight loss drug sales

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics